Abbvie Inc. ABBV
Revenue Intelligence Report • 56 quarters of SEC filing data • Updated 2026-03-15
Abbvie Inc. has a forecasted full-year revenue of $65B, a +6.6% year-over-year change, based on 56 quarters of SEC filing data. Key revenue drivers include SG&A (elasticity 0.86x). The ARDL model has 5.3% MAPE.
Investment Thesis
The econometric model achieves strong accuracy (5.3% MAPE), suggesting Abbvie Inc.'s revenue trajectory is well-characterized by its spending patterns. Sales & marketing spend shows a 0.86x elasticity, suggesting effective go-to-market execution.
Next FY Revenue
$65.2B
+6.6% YoY
SG&A Elasticity
0.86x
Model Accuracy
5.3% MAPE
Holdout validation: The model predicted $16B vs the actual $17B — an error of 4.1%.
Note:
Abbvie Inc. does not report R&D expenses separately. This analysis uses SG&A spending only.
Revenue Forecast
Quarterly Detail
| Quarter | Model Forecast | Actual | 95% Range | YoY Growth | Status |
|---|---|---|---|---|---|
| Q4 2025 | $16B | $17B | $14B – $18B | +5.5% | ✓ In range |
| Q2 2026 | $16B | $13B – $20B | +20.6% | ||
| Q3 2026 | $16B | $13B – $21B | +5.3% | ||
| Q4 2026 | $16B | $12B – $22B | +3.8% | ||
| Q1 2027 | $17B | $12B – $23B | -0.6% |
Seasonal Factors
Multiplicative seasonal adjustment:
These factors capture Abbvie Inc.'s systematic quarterly revenue patterns relative to the trend model.
A factor of 1.05 means that quarter typically runs 5% above the underlying trend; 0.95 means 5% below.
Factors are computed as the median of (actual / fitted) across all available quarters.
| Fiscal Quarter | Seasonal Factor | vs Trend | Interpretation | Obs. |
|---|---|---|---|---|
| FQ1 (Sep–Nov) | 1.0028 | +0.3% | In line with trend | 14 |
| FQ2 (Dec–Feb) | 1.0218 | +2.2% | In line with trend | 14 |
| FQ3 (Mar–May) | 0.9529 | -4.7% | -4.7% below trend | 13 |
| FQ4 (Jun–Aug) | 1.0424 | +4.2% | +4.2% above trend | 14 |
How Spending Drives Revenue
Reading this chart:
Each line shows the cumulative elasticity — how a 1% increase in spending translates to revenue growth over subsequent quarters. The effect builds over 4-5 quarters as investments compound.
Want this analysis for your portfolio?
I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.
Get in Touch